These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 24429079)
1. Acute antibiotic use in cystic fibrosis clinical trials: does it affect our assessment of clinical efficacy? Mayer-Hamblett N; Ratjen F Lancet Respir Med; 2013 Apr; 1(2):98-9. PubMed ID: 24429079 [No Abstract] [Full Text] [Related]
2. Airway-rehydrating agents for the treatment of cystic fibrosis: past, present, and future. Pettit RS; Johnson CE Ann Pharmacother; 2011 Jan; 45(1):49-59. PubMed ID: 21156814 [TBL] [Abstract][Full Text] [Related]
3. Comparison of hospital and home intravenous antibiotic therapy in adults with cystic fibrosis. Esmond G; Butler M; McCormack AM J Clin Nurs; 2006 Jan; 15(1):52-60. PubMed ID: 16390524 [TBL] [Abstract][Full Text] [Related]
4. Pulmonary exacerbation: towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trials. Bilton D; Canny G; Conway S; Dumcius S; Hjelte L; Proesmans M; Tümmler B; Vavrova V; De Boeck K J Cyst Fibros; 2011 Jun; 10 Suppl 2():S79-81. PubMed ID: 21658647 [TBL] [Abstract][Full Text] [Related]
5. Update in cystic fibrosis 2011. Ratjen F; McColley SA Am J Respir Crit Care Med; 2012 May; 185(9):933-6. PubMed ID: 22550209 [No Abstract] [Full Text] [Related]
6. Early lung disease in cystic fibrosis. Grasemann H; Ratjen F Lancet Respir Med; 2013 Apr; 1(2):148-57. PubMed ID: 24429095 [TBL] [Abstract][Full Text] [Related]
7. Antibiotic therapy in cystic fibrosis. Med Lett Drugs Ther; 1969 Feb; 11(4):14-5. PubMed ID: 5375095 [No Abstract] [Full Text] [Related]
8. Emerging therapies in cystic fibrosis. Anderson P Ther Adv Respir Dis; 2010 Jun; 4(3):177-85. PubMed ID: 20530065 [TBL] [Abstract][Full Text] [Related]
9. Azithromycin for improving pulmonary function in cystic fibrosis. Carr RR; Nahata MC Ann Pharmacother; 2004 Sep; 38(9):1520-4. PubMed ID: 15213312 [TBL] [Abstract][Full Text] [Related]
10. The relevance of the polymicrobial nature of airway infection in the acute and chronic management of patients with cystic fibrosis. Sibley CD; Parkins MD; Rabin HR; Surette MG Curr Opin Investig Drugs; 2009 Aug; 10(8):787-94. PubMed ID: 19649923 [TBL] [Abstract][Full Text] [Related]
11. A more objective approach to the evaluation of antimicrobial therapy in cystic fibrosis. Valletta EA; Rigo A; Bonazzi L; Zanolla L; Mastella G Acta Univ Carol Med (Praha); 1990; 36(1-4):44-5. PubMed ID: 2130717 [TBL] [Abstract][Full Text] [Related]
15. Changes in symptom scores as a potential clinical endpoint for studies of cystic fibrosis pulmonary exacerbation treatment. VanDevanter DR; Heltshe SL; Sanders DB; West NE; Skalland M; Flume PA; Goss CH; J Cyst Fibros; 2021 Jan; 20(1):36-38. PubMed ID: 32800708 [TBL] [Abstract][Full Text] [Related]
16. The role of azithromycin in patients with cystic fibrosis. Yousef AA; Jaffe A Paediatr Respir Rev; 2010 Jun; 11(2):108-14. PubMed ID: 20416547 [TBL] [Abstract][Full Text] [Related]
17. [Clinical picture, diagnosis and therapy of cystic fibrosis (mucoviscidosis)]. Bachmann KD Med Welt; 1974 Feb; 25(7):249-52. PubMed ID: 4816687 [No Abstract] [Full Text] [Related]